Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
- Published in:
- Gene Therapy, 2007, v. 14, n. 20, p. 1492, doi. 10.1038/sj.gt.3302994
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2007 AND VI 14 AND IP 20
Results: 6
1
2
Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
- Published in:
- Gene Therapy, 2007, v. 14, n. 20, p. 1448, doi. 10.1038/sj.gt.3303007
- By:
- Publication type:
- Article
3
Progress and Prospects: Gene Therapy Clinical Trials (Part 1).
- Published in:
- Gene Therapy, 2007, v. 14, n. 20, p. 1439, doi. 10.1038/sj.gt.3303001
- By:
- Publication type:
- Article
4
In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
- Published in:
- Gene Therapy, 2007, v. 14, n. 20, p. 1481, doi. 10.1038/sj.gt.3303003
- By:
- Publication type:
- Article
5
Gene delivery by the hSP-B promoter to lung alveolar type II epithelial cells in LAL-knockout mice through bone marrow mesenchymal stem cells.
- Published in:
- Gene Therapy, 2007, v. 14, n. 20, p. 1461, doi. 10.1038/sj.gt.3303006
- By:
- Publication type:
- Article
6
GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the TAT8-TK as a late gene in a pancreatic tumour model.
- Published in:
- Gene Therapy, 2007, v. 14, n. 20, p. 1471, doi. 10.1038/sj.gt.3303008
- By:
- Publication type:
- Article